Introduction
Angiogenesis is a process of growth and remodeling in vascular networks that is essential for normal development. In adulthood, angiogenesis is activated as a reparative process, for example, during wound healing (1, 2) . Aberrantly regulated angiogenesis can also be a component of disease (3) and can play a key role in tumor growth and metastasis (4), inflammatory diseases (5), diabetic retinopathy, and retinopathy of prematurity (6) .
Retinal angiogenesis in mice begins at postnatal day 0 (P0). The retinal vasculature initiates its expansion from the optic nerve head and migrates outwards along a preexisting network of astrocytes (7, 8) . This results in the formation of the superficial vascular plexus within the retinal ganglion cell layer during the first 8 days (9, 10) . Endothelial cells then migrate along nerve fibers to establish deep and intermediate vascular layers (9, 11) . Cell proliferation and migration are essential for angiogenesis and these cell responses are regulated by many different signaling pathways, including the VEGF, Notch, Wnt, FGF, BMP, and integrin signaling responses (9, (12) (13) (14) (15) (16) . VEGFA and CDC42 are known to regulate extension of the angiogenic front and filopodia formation in angiogenic tip cells (2, 17, 18) .
The Hippo signaling pathway is an evolutionarily conserved, pivotal regulator of cell proliferation and organogenesis. YAP and TAZ are key components of the Hippo signaling pathway and function as transcription cofactors that regulate downstream gene expression via association with DNA binding proteins such as TEAD1-4 (19, 20) . YAP and TAZ can drive the expression of genes that regulate cell proliferation and survival (diap1, bantam, cyclin E, and E2F1), the Hippo pathway (Kibra, Crb, and Fj), and cell-cell interaction (E-Cadherin, Serrate, Wingless, and Vein) (20) . The activity of YAP and TAZ is regulated by the LATS1 and LATS2 kinases. These kinases phosphorylate YAP and TAZ, thus preventing their nuclear translocation and regulating transcriptional activity. Although the function of YAP and TAZ in the nucleus has been subject to extensive studies (20, 21) , the role of these proteins in the cytoplasm is not fully understood.
In the present study, we used the mouse postnatal retina as a model for investigating the function of YAP and TAZ during angiogenesis. We show that YAP and TAZ are required for vascular network formation by regulating endothelial cell proliferation and migration and that the influence of YAP and TAZ on angiogenesis is gene dosage-dependent. Importantly, we show that cytoplasmic YAP, but not the nuclear form, is crucial for modulating endothelial cell migration by regulating the Rho family GTPase CDC42 activity. These findings identify a previously unrecognized role of cytoplasmic YAP in regulating angiogenesis via CDC42.
Results

YAP and TAZ are required for vascular development in the retina
We examined the expression of YAP in retinal endothelial cells. YAP was detected mainly in the cytoplasm in most retinal VECs (Fig. S1A-D) and in both the nucleus and cytoplasm in some VECs (Fig. S1C and D) . Whole mount retina staining also showed that YAP was mainly localized in the cytoplasm in both Submission PDF the migrating tip cells and the central region of retinal vessels (Fig. S1E) . To determine the function of YAP in retinal VECs, we bred the conditional Yap flox/flox allele with the Pdgfb-iCreERT2 mouse line to delete Yap in endothelial cells in a temporally regulated manner. The expression of Pdgfb-iCreERT2 in the developing retinal VECs was confirmed by breeding with Rosa26-Loxp-STOP-Loxp-tdTomato reporter mice (Fig. S2) (22) . Upon tamoxifen treatment from P1 to P3, Yap flox/flox ; Pdgfb-iCreERT2 (referred to as Yap cKO) mice did not show overt abnormalities when examined at P5 (Fig. S3) . To investigate whether the lack of phenotype in Yap cKO is due to a redundant function with TAZ (homolog of YAP in mammals), we generated endothelialspecific Taz knockout mice, Taz flox/flox ; Pdgfb-iCreERT2 (referred to as Taz cKO). Similar to the Yap cKO mice, the Taz cKO mice appeared normal without an obvious vascular phenotype (Fig.  S3) 137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204   2 www.pnas.org ------Footline Author   205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272 Submission PDF (Fig. S5 ). Severe reduction of vascular density in Yap/Taz cKO mutants led us to investigate the possibility that endothelial cell proliferation was affected. 5-ethynyl-2'-deoxyuridine (EdU) was delivered to P4 pups via intraperitoneal injection 16 hours before the analysis. We found that the number of proliferating endothelial cells was greatly reduced in the Yap/Taz cKO retinas compared with the littermate controls ( Fig. 1K-M) , suggesting that YAP and TAZ are required for endothelial cell proliferation during angiogenesis.
Angiogenic sprouting is promoted by active filopodial protrusions and tip cell migration (23) . To determine whether the vascular defect in Yap/Taz cKO mice involves tip cell migration, we examined the abundance and morphology of tip cells. The number of tip cells was significantly reduced in Yap/Taz cKO mice (Fig. 1C, F, J and S3E) . Furthermore, tip cells in the double mutant mice exhibited only a few filopodia extending from vessel termini ( Fig. 1N and O) . The reduced vascular extension and the morphology of the tip cells in Yap/Taz cKO mice led us to investigate whether YAP and TAZ are necessary for VEC migration. During retinal angiogenesis, vasculature expands from the optic stalk at P1 and reaches the periphery by about P8 (24 (25, 26) . The Lats1/2 cKO retinas exhibited a migration defect with reduced extension distance compared with the control mice ( Fig. 2A, D, and G) . The angiogenic network in Lats1/2 cKO mice also displayed hyperplasia with increased vascular complexity evident by a 60% increase in branchpoints and reduced vascular area (Fig. 2B, E, H , and I). The proliferation rate of VECs was significantly increased whereas vascular area was reduced in Lats1/2 cKO retina (Fig.  2K-M) and expression of YAP target genes was significantly increased in Lats1/2 cKO endothelial cells (Fig. S5) . These results contrasted with the proliferation phenotype and gene expression in the Yap/Taz cKO retina (Fig. 1K-M and S5) . Although other effectors might be affected in the Lats1/2 cKO mice, these data suggest that nuclear YAP/TAZ might be mainly required for VECs proliferation, but not for cell migration.
Loss of CDC42 caused abnormal vessel morphology and migration defect
The Rho GTPase CDC42 has been shown to be required for blood vessel formation during vasculogenesis by promoting filopodia formation in endothelial tip cells (17, 18, 27, 28) . To   273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339 ; not significant, S112A; YAPS112A. (E) Active-CDC42 pull-down assay of YAPS127D-lentivirus-infected (S127D) and YAPS112A-adenovirus-infected (S112A) HUVECs. CDC42, YAP, and GAPDH expression levels are detected by western blot analysis. Scale bars represent 50 μm (A and C).
confirm the activity of CDC42 in the formation of filopodia, we combined the Cdc42 flox/flox allele (29) with Pdgfb-iCreERT2 mice to generate an endothelial specific deletion of Cdc42, Cdc42 flox/flox ; Pdgfb-iCreERT2 (referred to as Cdc42 cKO). Cdc42 cKO retinas exhibited reduced radical extension of vasculature at P5 (Fig 3A,  D, and G) . The vascular density was also reduced in Cdc42 cKO mice (Fig. 3B, E, and I ). The number of tip cells at the sprouting front did not show a significant difference between Cdc42 cKO and the littermate controls (Fig. 3C, F 
and J).
Cdc42 cKO retina tip cells had few filopodia (Fig. 3M) , and lacking of filopodia in tip cells was also observed in Yap/Taz cKO and Lats1/2 cKO retinas (Fig. 3L, N) . Quantitative analysis showed a significant decrease in filopodia density in these mice (Fig. 3O) . The converging phenotype of endothelial specific deletion of Yap/Taz, Cdc42, or Lats1/2 in the filopodia-mediated vascular sprouting and branching in the retina suggests that these molecules might operate in a common pathway in angiogenic tip cell development.
YAP and TAZ regulate CDC42 activity in migrating endothelial cells
The similar tip cell phenotype in Yap/Taz cKO and Cdc42 cKO mice lead us to examine how YAP/TAZ regulates endothelial cell migration and whether YAP and TAZ regulate CDC42 activity and its cellular localization in endothelial cells. We depleted YAP and TAZ in vitro in human umbilical vein endothelial cells (HUVECs) using lentiviruses expressing short hairpin RNAs targeting human YAP and TAZ, and assessed HUVECs migration by a wound healing scratch assay. To distinguish the effect of proliferation from cell migration, HUVECs were treated with hydroxyurea for 4 hours before the migration assay. Quantification analysis of the invaded area 16 hours after the scratch demonstrated that knocking down YAP and TAZ in HUVECs inhibited cell migration (Fig. 4A and B) . The cell migration defect was exacerbated when both YAP and TAZ were knocked down, consistent with the mouse in vivo data showing that YAP and TAZ are required for cell migration and that this requirement is gene dosage-dependent.
We found that, while the total CDC42 level did not change, the level of active CDC42 was greatly reduced upon knockdown of YAP and TAZ (Fig. 4C) . For better visualization of active CDC42 in a single cell, we transfected HUVECs with a GFP-tagged CDC42/RAC interactive binding domain of neural Wiskott Aldrich syndrome protein (GFP-N-WASP) (30) , which binds to endogenous active CDC42. The active CDC42 was located at the lamellipodial edge of the control HUVECs (Fig.  4D) . In YAP/TAZ knockdown HUVECs, only active CDC42 was diminished in the protruding edge (Fig. 4D) , while CDC42 localization was not disrupted (Fig. 4E) , suggesting that YAP and TAZ regulate CDC42 activation rather than its cellular localization in HUVECs. The migration defect in YAP/TAZ knockdown HUVECs can be rescued by a constitutively active form of CDC42 (CDC42F28L) (Fig. 4F) , which is capable of spontaneously exchanging GDP for GTP (31, 32) , suggesting that YAP/TAZ regulation of the HUVEC migration at least in part channels through CDC42 activity. To confirm the effect of YAP/TAZ in vivo, we examined the expression of phosphorylated-N-WASP, an effector of CDC42 (33) , in the developing mouse retinal vasculature. Phosphorylated-N-WASP was detected in the migrating endothelial cells in control retinas at P11; however, the level of phosphorylated-N-WASP was greatly reduced in the Yap/Taz cKO retinal VECs (Fig. 4G) . These data suggest that YAP/TAZ regulate cell migration through activating CDC42 mediated N-WASP pathway in vivo. Moreover, CDC42 activity was down regulated in the brain endothelial cells from Yap/Taz cKO mice. (Fig. 4H) . Collectively, these observations indicate that the endothelial migration defect in the Yap/Taz cKO retinas is at least partially due to the downregulation of CDC42 activity.
Cytoplasmic YAP promotes endothelial cell migration YAP is a mechanical sensor whose cellular localization changes in response to various environmental stimuli including cell-cell interaction and alterations of cytoskeletal dynamics (34, 35) . We assessed whether YAP cellular localization affected CDC42 activity. When HUVECs were at low density, YAP was localized in the nucleus and translocated to the cytoplasm when cells reached confluency (Fig. S6A) . Consequently, the level of phosphorylated YAP was greatly upregulated in the overconfluent cells (Fig. S6B) . The active CDC42 level also increased dramatically in the over-confluent cells compared with the cells at low density (Fig. S6B) . In the wound scratch assay on overconfluent HUVECs, YAP remained in the cytoplasm while the cells migrated (Fig. S6C) , suggesting a pro-migratory role of the cytoplasmic YAP. The decrease of CDC42 activity in LATS1/2 knockdown HUVEC and Lats1/2 cKO brain endothelial cells (Fig. S6D and E) further supports the hypothesis that the cytoplasmic YAP regulates the migration of endothelial cells.
To further investigate whether cytoplasmic YAP promotes cell migration and activates CDC42, we transduced HUVECs with a lentivirus expressing YAPS127D. Substitution of Ser127 with Asp (S127D) generates a YAP protein that is sequestered in the cytoplasm mimicking phospho-YAP (Fig. S7) . HUVECs
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treated with lenti-YAPS127D migrated with a trend faster than cells treated with the control lentivirus (Venus), although the difference in migration did not reach significance (Fig. 5A  and B) . YAPS127D did partially rescue the migration defects caused by shRNA-mediated YAP/TAZ knockdown, suggesting that phospho-YAP promotes endothelial cell migration (Fig. 5A  and B) . We further examined the effect of nuclear YAP, using a constitutively active form of nuclear YAP (YAPS112A, in which Serine 112 is mutated to Alanine) in retinal angiogenesis, by breeding Pdgfb-iCreERT2 with transgenic mice under the control of CAG-LoxP-CAT-Stop-Loxp cassette. No substantial effect on retinal angiogenesis was detected in Tg-YAPS112A (Fig.  S8) , suggesting that nuclear YAPS112A overexpression does not alter neovasculature formation in the retina. Unlike the Lats1/2 cKO phenotype, VEC proliferation was not upregulated by YAPS112A although YAP targets genes (Ctgf and Cyr61) were upregulated in VECs (Fig. S8) . Notably, YAPS112A did not rescue the migration defect in YAP/TAZ knockdown HUVECs (Fig. 5C and D) . To examine whether this pro-migration function of YAP is through activation of CDC42, we overexpressed YAPS127D in HUVECs and found that the level of active CDC42 was greatly increased (Fig. 5E ). The reduction of active CDC42 with shRNA-mediated YAP/TAZ knockdown was also rescued by YAPS127D, but not by YAPS112A expression (Fig. 5E ). These results indicate an important role of cytoplasmic YAP in promoting cell migration by activating CDC42 (Fig. S9) . The partial rescue of the cell migration and CDC42 activity with YAPS127D could be due to the fact that only the phospho-YAP mimic is overexpressed in the HUVECs in which both YAP and TAZ are knocked down. Although YAP and TAZ play redundant roles in regulating retinal angiogenesis, they may have distinct functions in interacting with different proteins in the cytoplasm to regulate cell migration.
Discussion
Angiogenesis is a highly regulated process. This reflects the potentially detrimental consequences of a deficiency or an excess of blood vessels. The Hippo signaling pathway has been implicated in vascular development (36) (37) (38) but the underlying mechanisms have not been fully described. In this study, we found that the cytoplasmically localized phospho-YAP, which is not involved in transcription, plays an important role in promoting cell migration via activating CDC42.
Cell autonomous function of YAP/TAZ vascular development in vivo. A migration defect in epithelial-mesenchymal transition (EMT) during cardiac cushion formation causes early embryonic lethality instigated by deletion of a floxed Yap allele using Tie2-Cre. This made it difficult to study YAP function in the developing vasculature (37) . Global knockdown of Yap via siRNA injection in mice revealed that YAP is important for mediating the stability of endothelial cell junction and vascular remodeling (36) , however, the cell autonomous function of YAP could not be addressed due to the systemic distribution of the siRNA. We report here that deletion of Yap using endothelial cell-expressing Pdgfb-iCreERT2 allows for assessment of postnatal retinal vascular development. Combined endothelial deletion of Yap and Taz in mice revealed gene dosage-dependent effects on retinal vascular sprouting, endothelial cell proliferation, and migration.
We found that YAP target genes such as Ctgf and Cyr61 are down regulated in Yap/Taz cKO brain endothelial cells, while they are up-regulated in Lats1/2 cKO endothelial cells, suggesting that transcriptional activity of YAP/TAZ might contribute to the regulation of proliferation in endothelial cells. In contrast to Yap/Taz cKO and Lats1/2 cKO, YAPS112A overexpression alone is insufficient for retinal VEC proliferation, and the level or strength of YAP activity or additional factors such as TAZ may control EC proliferation. Furthermore, nuclear YAPS112A overexpression in transgenic mice does not alter angiogenesis in the retina as opposed to the vascular defects in Lats1/2 cKO mice, suggesting that LATS1/2 could regulate other effectors, in addition to the subcellular localization of YAP/TAZ for the vascular morphogenesis.
The majority of studies of YAP and TAZ report their transcriptional activity in the nucleus via association with TEAD transcription factors and that phosphorylation of YAP and TAZ by the upstream kinases induces their cytoplasmic retention and degradation (20) . Studies have revealed that phosphorylated YAP and TAZ are associated with 14-3-3 to bind to proteins in the cytoplasmic and tight junctions (39, 40) . In kidney cells, it has been reported that cytoplasmic YAP and TAZ interact with angiomotin (AMOT) to facilitate the localization of YAP and TAZ to tight junctions and to promote phosphorylation by the upstream kinases in the Hippo pathway (41) . In addition, cytoplasmically localized phospho-YAP and -TAZ have been shown to interact with DVL to inhibit Wnt/β-catenin and SMAD signaling (42, 43) . Expression of YAPS112A in YAP/TAZ knockdown HUVECs cannot rescue the migration defect while the cytoplasmic mutant YAPS127D can, suggesting that cytoplasmic YAP but not nuclear YAP is required for cell migration. Hence, our data reveal a previously unrecognized function of cytoplasmic YAP/TAZ in the regulation of endothelial cell migration.
The crosstalk between Hippo signaling and CDC42. The small Rho family GTPase CDC42 is required for lumen formation during vasculogenesis and filopodia formation in endothelial cells (17, 27, 44) . When Cdc42 was deleted in endothelial cells using Cdh5(PAC)-CreERT2 (17), vascular extension was not significantly changed between the Cdc42 mutant and littermate controls. In our study, we observed a reduced vascular extension phenotype using Pdgfb-iCreERT2 to delete the floxed Cdc42 allele. The difference in the phenotype between these two studies could be due to the distinct Cre line used and the timing of tamoxifen administration. A previous study reported that deletion of Cdc42 in kidney progenitor cells resulted in reduced YAP nuclear localization and target gene expression, suggesting that CDC42 acts upstream of YAP in mouse kidney development (45) . Our study demonstrated that cytoplasmic YAP promoted CDC42 activation, providing a complementary mechanism of crosstalk between the Hippo pathway and CDC42. How cytoplasmic YAP regulates CDC42 activity in endothelial cell migration remains to be defined. A recent study indicates that YAP regulates RhoA activity through the controlling the expression of ARHGAP29 (Rho GTPase activating protein) (46) . While CDC42 is not able to be directly activated by YAPS127D, there is a possibility that cytoplasmic YAP regulates CDC42-GEF or CDC42-GAP activity in migrating endothelial cells. The result of the rescue experiment using CDC42F28L, which can bind to GTP in the absence of GEF, supports this hypothesis.
YAP and TAZ join a collection of cellular factors and signaling molecules with the known ability to promote vascular sprouting and angiogenesis. Although our findings clearly demonstrate that YAP can activate CDC42 activity to promote endothelial cell migration, multiple mechanisms likely contribute. More evidence continues to demonstrate crosstalk between different signaling pathways to control vascular development. The Notch, VEGF, and BMP signaling pathways have been shown to play important roles in regulating vascular sprouting and tip cell formation during angiogenesis (9, (12) (13) (14) . One report showed that BMP9 crosstalks with the Hippo pathway by repressing YAP target genes in endothelial cells (47) . It seems possible that, in turn, YAP and TAZ could regulate BMP, Notch, and other pathways to control vascular development. Future investigations would need to identify the cellular mechanism underlying how cytoplasmic YAP activates CDC42 and to test the potential synergistic activities between YAP and regulators in other signaling pathways. The new findings of cytoplasmic YAP activity may help to develop 545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 
